Tesamorelin dosage calculator

Tesamorelin dosage chart: units for 5 mg and 10 mg vials

Unlike most research peptides, tesamorelin has an approved label to anchor a dosage chart: the FDA-approved products for HIV-associated abdominal fat are labelled at 1.4 mg once a day under the skin for Egrifta SV and 1.28 mg once a day for Egrifta WR (the original Egrifta was 2 mg a day). Outside that use, community protocols most often cite 1 to 2 mg a day. This page does not recommend a dose; the chart shows what each amount looks like on a U-100 syringe for the usual vial set-ups.

Daily dosing means a vial is used over many days, so pick a water volume that puts your dose on a clear mark and gives a vial that finishes within its beyond-use date. A 10 mg vial holds five 2 mg doses, or seven at the Egrifta SV dose of 1.4 mg.

• 5 mg + 2 mL (2.5 mg/mL): 1 mg = 40 units · 2 mg = 80 units
• 10 mg + 2 mL (5 mg/mL): 1 mg = 20 units · 2 mg = 40 units
• 10 mg + 3 mL (3.33 mg/mL): 1 mg = 30 units · 2 mg = 60 units

How the tesamorelin calculation works

Tesamorelin vials are labelled in milligrams, while daily doses are usually discussed in milligrams or micrograms. The calculator converts the vial total to mcg, divides by your BAC water volume to find concentration, then divides your target dose by that concentration.

Because tesamorelin is reconstituted and then used over several days, picking a water volume that keeps your daily dose on clear unit marks reduces the chance of a misread between doses.

• 5 mg vial = 5,000 mcg total
• 5,000 mcg / 2 mL = 2,500 mcg per mL
• 1,000 mcg target = 0.4 mL draw

Tesamorelin 5 mg vial with 2 mL example

A 5 mg tesamorelin vial mixed with 2 mL gives 2.5 mg/mL, or 2,500 mcg/mL.

A 1 mg (1,000 mcg) dose is 0.4 mL, which equals 40 units on a U-100 syringe. A 2 mg dose would be 0.8 mL, or 80 units.

• 5 mg / 2 mL = 2.5 mg/mL
• 1,000 mcg / 2,500 mcg per mL = 0.4 mL = 40 U-100 units
• 2,000 mcg / 2,500 mcg per mL = 0.8 mL = 80 U-100 units

Use less water for a smaller tesamorelin draw

If a 40-unit draw feels large, reconstituting the same 5 mg vial in 1 mL doubles the concentration to 5 mg/mL.

At 5 mg/mL a 1 mg dose halves to 0.2 mL, or 20 units. Less bacteriostatic water raises the concentration and shrinks every draw — re-run the calculator after changing the water amount so the units match.

• 5 mg / 1 mL = 5 mg/mL → 1 mg = 0.2 mL = 20 units
• Less BAC water = higher concentration = smaller draw
• Keep the draw within your syringe's capacity

How much BAC water for a 10 mg tesamorelin vial

A 10 mg vial in 2 mL gives 5 mg/mL, so a 1 mg dose is 0.2 mL (20 units), 1.5 mg is 0.3 mL (30 units) and 2 mg is 0.4 mL (40 units). In 3 mL it is about 3.33 mg/mL, putting 1 mg at 30 units and 2 mg at 60 units.

A 10 mg vial holds about ten 1 mg doses or five 2 mg doses. With daily dosing that is one to two weeks per vial, so check the reconstituted beyond-use date covers it.

• 10 mg / 2 mL = 5 mg/mL → 1 mg = 20 units, 2 mg = 40 units
• 10 mg / 3 mL = 3.33 mg/mL → 1 mg = 30 units, 2 mg = 60 units
• About ten 1 mg doses or five 2 mg doses per vial

How to reconstitute a 10 mg tesamorelin vial

A 10 mg vial is the common research size and has no manufacturer label, so the water volume is your choice. 2 mL gives 5 mg/mL, where 1 mg is 20 units; 3 mL gives about 3.33 mg/mL, where 1 mg is 30 units and small doses are easier to read. Because the vial is used over a week or more, pick the volume that keeps your daily dose on a clear mark.

Wipe both stoppers with alcohol, draw the bacteriostatic water, and let it run slowly down the inside wall of the vial instead of onto the powder. Swirl or roll gently until the solution is clear — do not shake it — then label the vial with the date and the water you added.

• 10 mg + 2 mL = 5 mg/mL → 1 mg = 20 units, 1.4 mg = 28 units, 2 mg = 40 units
• 10 mg + 3 mL = 3.33 mg/mL → 1 mg = 30 units, 2 mg = 60 units
• Seven 1.4 mg doses or five 2 mg doses per 10 mg vial

Egrifta SV and Egrifta WR: how the approved vials are mixed

The two approved products are mixed differently and their labels say they cannot be swapped for each other. Egrifta SV is a 2 mg vial mixed with 0.5 mL of the sterile water supplied (4 mg/mL); the dose is 1.4 mg, which is 0.35 mL or 35 units on a U-100 syringe. Egrifta WR is an 11.6 mg vial mixed with 1.3 mL of the bacteriostatic water supplied (8 mg/mL); the dose is 1.28 mg, which is 0.16 mL or 16 units, and one vial gives seven daily doses.

Their storage rules after mixing are opposite to what most people assume. The Egrifta SV label says to inject immediately after mixing, throw away what is left, and not refrigerate or freeze the mixed solution. The Egrifta WR label says to keep the mixed vial at room temperature (20–25 °C) and discard it 7 days after mixing.

• Egrifta SV: 2 mg + 0.5 mL sterile water = 4 mg/mL → 1.4 mg = 0.35 mL = 35 units
• Egrifta WR: 11.6 mg + 1.3 mL BAC water = 8 mg/mL → 1.28 mg = 0.16 mL = 16 units
• SV: use immediately · WR: room temperature, discard after 7 days

How long tesamorelin lasts after reconstitution

For the approved products, the label decides: Egrifta SV is used immediately after mixing, and Egrifta WR is kept at room temperature and discarded 7 days after mixing. Research vials have no label, so there is no tested shelf life after mixing; keep the vial refrigerated and protected from light, and follow the beyond-use date your supplier or pharmacy gives. Multi-dose vials in clinical settings are commonly discarded 28 days after first puncture unless the manufacturer says otherwise.